Infectious Disease

Major depressive episodes following COVID-19 illness differ from the typical appearance

Source / information

Disclosure:
Perlis reports that it has received consulting fees from Burrage Capital, Genomind, RID Ventures and Takeda; Receiving personal fees from Belle Artificial Intelligence; and participation in Outermost Therapeutics and Psy Therapeutics. The other authors do not report any relevant financial information.

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact [email protected].

Back to Healio

Apparent major depressive episodes after contracting COVID-19 appeared to be different from those normally seen in adults, according to the results of a survey in a research letter published on JAMA Network Open.

“The rates of severe depressive symptoms are increased after an acute infection with SARS-CoV-2” Roy H. Perlis, MD, MSc, of the Department of Psychiatry at Massachusetts General Hospital and colleagues. “A key question is whether such symptoms represent a general consequence of stress related to an acute illness or whether they reflect more specific consequences related to the COVID-19 pathophysiology itself. To investigate this possibility, in this survey we compared the characteristics of major depression in people with and without a previous COVID-19 illness.

Infographic data derived from: Perlis RH, et al. JAMA network open. 2021; doi: 10.1001 / jamanetworkopen.2021.16612.

The researchers used a commercial multi-panel provider to conduct 12 waves of Qualtrics’ Internet non-likelihood survey among people aged 18 or older approximately every month between May 2020 and February 2021. They included sociodemographic questions related to gender, income, age, education, urbanity, and self-identified race / ethnicity according to five U.S. census categories with the aim of incorporating race and ethnicity to determine how these and other sociodemographic factors played a role in the responses play COVID-19 disease and quarantine. The participants indicated whether and when, according to their medical diagnosis, they had COVID-19 disease or whether they had a positive SARS-CoV-2 test result. They completed Patient Health Questionnaire-9 (PHQ-9) to measure depressive symptoms, with at least moderate symptoms defined with a score of 10 or higher. The logistic regression with moderate or severe depressive symptoms served as the dependent variable and socio-demographic characteristics as the independent variables. Perlis and colleagues compared the means for each symptom of depression and anxiety between participants with or without prior COVID-19. They also rated the prevalence of depressive symptoms by months that have passed since COVID-19.

A total of 91,791 people completed the PHQ-9. Of these participants, 67% were female, 10.5% black, 7.3% Hispanic American, 5.8% Asian, 40.1% had a college degree, 24.2% were urban, and 17.6% were rural. Participants had an average age of 42.34 years and an average annual income of $ 49,000. In addition, 6.5% reported a previous COVID-19 clinic diagnosis or test result, and 31.2% reported moderate or severe depressive symptoms. Regression models for depressive symptoms showed significant associations between previous COVID-19 status and gender, income, black vs. white race, and urban vs. rural setting. Perlis and colleagues observed the largest differences in PHQ-9 scores for individual symptoms in those with or without prior COVID-19 for suicidality and motor symptoms. The risk of depressive symptoms increased with longer duration with each additional month after an acute illness.

“By and large, our results may indicate a different disease process in at least a subset of individuals,” wrote Perlis and colleagues. “At the very least, these differences suggest that there is a need to better understand the differences and similarities between post-COVID-19 depressive symptoms and those associated with a typical major depressive disorder.”

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact [email protected].

Back to Healio

COVID-19 Resource Center

COVID-19 Resource Center

Related Articles